SCHEMBL8335612

SCHEMBL8335612

CCCC1CCC1N=S(=O)=O.CCOc1ccc(CC(=O)NC(=S)NC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.40
▸ ALPI P09923 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ HDAC10 Q969S8 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ NLRP3 Q96P20 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339931 0.92 TDP1 (0.48) LMNATDP1SMN1; SMN2RAB9AALDH1A1
SCHEMBL8335900 0.85 TDP1 (0.46) LMNAPKMTDP1SMN1; SMN2RAB9A
SCHEMBL8340529 0.68 TDP1 (0.44) LMNATDP1GAACNR2SMN1; SMN2
SCHEMBL8335999 0.67 TDP1 (0.51) LMNATDP1CNR2SMN1; SMN2NPC1
SCHEMBL169824 0.67 TDP1 (0.76) LMNATDP1GAASMN1; SMN2NPC1
SCHEMBL8352827 0.67 SMN1; SMN2 (0.60) LMNAALPIPKMTDP1CNR2
SCHEMBL8336596 0.67 TDP1 (0.53) LMNATDP1CNR2SMN1; SMN2NPC1
SCHEMBL8340007 0.66 TDP1 (0.49) LMNATDP1CNR2SMN1; SMN2RAB9A
SCHEMBL7916079 0.65 SMN1; SMN2 (0.57) LMNAALPIPKMTDP1CNR2
SCHEMBL8340133 0.64 TDP1 (0.37) LMNAPKMTDP1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback